Heme/Onc Fellow @NorthwesternMed |@umkcIM and @CCLRI research fellow alum | GI Onc/Pancreatic/Bile duct cancer | 🇹🇭/🏳️🌈 | Tweets=my own
Chicago, IL
Joined February 2020
- Tweets290
- Following756
- Followers342
- Likes1.1K
Deeply honored to become a Heme/Onc fellow at @NorthwesternMed starting next July!
Super grateful to my family, friends, mentors, @umkcIM, and everyone who has supported me throughout the long journey.
@NUHemOncFellow @hemeoncfellow #Match2025 #HemeOnc
Our correspondence is now available on @TheLancet!
Differences in HCC etiology may contribute to the positive result of camrelizumab plus rivoceranib in CARES-310 trial, in contrast to other IO+TKI trials. Thank you @MarcRothMD @SLCI_KC for the support.
thelancet.com/journals/lance…
Happy to present a mini oral presentation about identifying patient population that may benefit more from double ICI regimen compared to those with single ICI. Thank you for the gracious support and mentorship from @dhruvsxu @RamSubraMD
#WCLC24 @hemeoncfellow @IASLC
Submitted the ERAS application for Hematology/Oncology fellowship!
Excited about the upcoming interview season and looking forward to meeting everyone there.
#Oncology #Hematology #hemeonc #FellowshipMatch #medtwitter #Match2025
8
53
3,806
Happy to be accepted for presenting a mini oral abstract at 2024 WCLC on potential strategy to improve immunotherapy treatment in lung cancer!
Will be more than happy to meet and discuss with everyone there! #lungcancer #lcsm #wclc
I hope that one day this will be included in our lung cancer screening strategy. People without smoking history deserves better screening!
🔥#ASCO24 #LCSM Oral
🔥#8009 Lung cancer screening in heavy smokers (HS) and non-smokers with lung cancer family history (LCFH)
🎙️Dr. Pan-Chyr Yang
🎯LCFH showed a📈detection compared to HS
✅🇹🇼National Screening
@OncoAlert @ASCO
Arriving a bit late due to unfortunate circumstances but here I am!
#ASCO24
The wave of periop targeted/IO for NSCLC continues to rock
🔥 Results of phase 3 ALINA study now published in @NEJM
2 yrs adjuvant alectinib v chemotherapy
✅ DFS HR 0.24
✅ 🧠 DFS HR 0.22
IMO, practice changing for our patients w/ ALK positive early-stage NSCLC
@ALKPositiveinc @ALKpositiveINT @OncoAlert #lcsm
1
2
441
More than happy to have a review on predictive biomarkers for irAE.
Prospective studies that capture irAE proactively better and incorporating scoring system to predict irAE are the future directions.@dhruvsxu @RamSubraMD @Khan7013 @SLCI_KC @Cancers_MDPI
mdpi.com/2072-6694/16/6/1225
Happy to present the poster on KEAP1/STK11, immune pathways, and survival outcomes.
Thank you @dhruvsxu @RamSubraMD for mentoring me on this project, and thank you Dr. Helen Ross for discussing this in the Poster Discussion Session at #NACLC23
Drugs being more of a tongue twister day by day – at Kansas City, MO
WHO assigns international nonproprietary names (INNs), aka common names or generic names, to drugs upon request from developers
We all know T-DXd (DS8201a) = trastuzumab deruxtecan, SG (IMMU-132) = sacituzumab govitecan...
but what about newer #ADCs? What INNs will they have?
2
270
Just published in JTO: authors.elsevier.com/c/1hcLO…
STK11 and KEAP1 mutations confer less OS and PFS benefit in metastatic NSCLC, but ICI doublets might overcome the resistance.
Thank you @RamSubraMD @dhruvsxu for guiding this project through!
A great pleasure to be able to present at ACP Annual Meeting this week for a case report on recurrent DVT stemming from congenital anatomical abnormality (in this case: hypoplastic IVC).
3
23
1,018
Finished my first ITE… Such a long day, lots of thinking but more of guesses 😂. Will know how it went in the next couple of weeks, but for now the brain needs to rest
1
9
Thank you very much for giving me the opportunity to be a part of @umkcIM! I’m looking forward to work and learn there soon.
Can’t wait to meet everyone there too!
Beyond excited to welcome our new class of interns! Congratulations and we can't wait to see you! 🎉🥳
#MatchDay2022
#internalmedicine
6
13
Fingers crossed. Good luck everyone 🤞
Tomorrow at 9 am ET, applicants learn if (but not where) they matched. As a reminder - match status notification is sent by courtesy email and is found in the R3 system. #Match2022
1
7